Clinical trials
Phase 1 Uterine Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2011 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 3 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Terminated | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Revolution Medicines, Inc. | 2 |
| Advaxis, Inc. | 1 |
| Astellas Pharma Inc | 1 |
| Atavistik Bio, Inc | 1 |
| City of Hope Medical Center | 1 |
| GAAD Medical Research Institute Inc. | 1 |
| ImmunoFrontier, Inc. | 1 |
| Imperial College London | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Kumquat Biosciences Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Neoplasms | 24 |
| Ovarian Neoplasms | 15 |
| Uterine Cervical Neoplasms | 10 |
| Breast Neoplasms | 8 |
| Endometrial Neoplasms | 7 |
| Lung Neoplasms | 6 |
| Prostatic Neoplasms | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Head and Neck Neoplasms | 5 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.